Immunogenicity and Safety of Group A, C, Y & W-135 Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine

NCT01897402 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

525

Enrollment

INDUSTRY

Sponsor class

Conditions

Meningococcal Meningitis
Meningococcal Infections

Interventions

BIOLOGICAL: Test Vaccine
BIOLOGICAL: US Licensed Vaccine

Sponsor

JN-International Medical Corporation